Viewing Study NCT06205706


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-06-21 @ 4:47 PM
Study NCT ID: NCT06205706
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-19
First Post: 2023-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
Sponsor: BioInvent International AB
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Non Small Cell Lung Cancer View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None solid tumors View